BREAKING: Kythera Biopharmaceuticals Inc. said Monday that a U.S. Food and Drug Administration advisory panel voted unanimously to recommend approval of the company's injectible drug to treat submental fat in adults, more commonly referred to as a double chin.
Read HERE.
No comments:
Post a Comment
All comments must be signed.